We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 13, 2021

First-Line Immunotherapy-Based Combinations for Metastatic Renal Cell Carcinoma

European Urology Oncology


Additional Info

European Urology Oncology
First-Line Immunotherapy-Based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis
Eur Urol Oncol 2021 Mar 20;[EPub Ahead of Print], F Quhal, K Mori, A Bruchbacher, I Resch, H Mostafaei, B Pradere, VM Schuettfort, E Laukhtina, S Egawa, H Fajkovic, M Remzi, SF Shariat, M Schmidinger

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading